WeGovy and Ozempic are two medications used to treat type 2 diabetes. WeGovy is a relatively new medication that was approved by the FDA in June 2021, while Ozempic has been on the market since 2017.

According to the sources provided, the cost of WeGovy is currently unknown as it is a new medication and has not yet been listed on any drug pricing websites. On the other hand, the cost of Ozempic can vary depending on the dosage and location.

SingleCare [2] states that the average cost of Ozempic without insurance is around $850 for a 1-month supply. However, GoodRx [3] provides a more detailed cost comparison for both medications. The cost of Ozempic ranges from $856 to $1,035 for a 1-month supply, depending on the dosage and location. Meanwhile, WeGovy is not yet listed on their website.

It is important to note that the cost of these medications may be covered by insurance, and the amount paid out of pocket can vary depending on the individual's insurance plan. Patients should consult with their healthcare provider and insurance company to determine the exact cost of these medications for their specific situation.

In conclusion, while the cost of WeGovy is currently unknown, the cost of Ozempic can vary depending on the dosage and location. Patients should consult with their healthcare provider and insurance company to determine the exact cost of these medications for their specific situation.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/WEGOVY
[2] https://www.singlecare.com/blog/wegovy-vs-ozempic/
[3] https://www.goodrx.com/classes/glp-1-agonists/wegovy-vs-ozempic